Bipolar disorder and metabolic syndrome: An international perspective

Journal of Affective Disorders

Volumn 126, Issue 3, 2010, Pages 366-387

  McIntyre, Roger S ^a,b,c   Danilewitz, Marlon ^c,d   Liauw, Samantha S ^c,e   Kemp, David E ^f   Nguyen, Ha T T ^c   Kahn, Linda S ^g   Kucyi, Aaron ^c   Soczynska, Joanna K ^b,c   Woldeyohannes, Hanna O ^c   Lachowski, Angela ^c   Kim, Byungsu ^h   Nathanson, Jay ^a,c   Alsuwaidan, Mohammad ^a,c   Taylor, Valerie H ⁱ  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d YESHIVA UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g UNIVERSITY AT BUFFALO   (United States)

^h University of Ulsan College of Medicine   (South Korea)

ⁱ MCMASTER UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; Metabolic syndrome

Indexed keywords

ARTICLE; ASIA; AUSTRALIA; BIPOLAR DISORDER; DISEASE ASSOCIATION; EUROPE; HUMAN; MANIA; MEDLINE; METABOLIC SYNDROME X; NORTH AMERICA; POPULATION; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLE SIZE; SOUTH AMERICA; TREATMENT RESPONSE;

ADIPONECTIN; BIPOLAR DISORDER; BLOOD GLUCOSE; CHOLESTEROL; CLUSTER ANALYSIS; COMORBIDITY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; HUMANS; IATROGENIC DISEASE; LONG-TERM CARE; METABOLIC SYNDROME X; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 77957338107     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.04.012     Document Type: Article

References (62)

1. American Diabetes Association Consensus development conference on antipsychotic drugs and obesity and diabetes Diab. Care 27 2 2004 596 601 February
2. A.B. Birkenaes, A.J. Sogaard, J.A. Engh, H. Jonsdottir, P.A. Ringen, A. Vaskinn, S. Friis, K. Sundet, S. Opjordsmoen, and O.A. Andreassen Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population J. Clin. Psychiatry 67 3 2006 425 433 March
3. O. Bosello, and M. Zamboni Visceral obesity and metabolic syndrome Obes. Rev. 1 1 2000 47 56
4. J. Cardenas, M.A. Frye, S.L. Marusak, E.M. Levander, J.W. Chirichigno, S. Lewis, S. Nakelsky, S. Hwang, J. Mintz, and L.L. Altshuler Modal subcomponents of metabolic syndrome in patients with bipolar disorder J. Affect. Disord. 106 1-2 2008 91 97 February
5. H.H. Chang, C.H. Chou, P.S. Chen, P.W. Gean, H.C. Huang, C.Y. Lin, Y.K. Yang, and R.B. Lu High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan J. Affect. Disord. 117 1-2 2009 124 129 September
6. C.U. Correll, A.M. Frederickson, J.M. Kane, and P. Manu Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophr. Res. 89 1-3 2007 91 100
7. C.U. Correll, A.M. Frederickson, J.M. Kane, and P. Manu Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics Bipolar Disord. 10 7 2008 788 797 November
8. B.G. Druss, W.D. Bradford, R.A. Rosenheck, M.J. Radford, and H.M. Krumholz Quality of medical care and excess mortality in older patients with mental disorders Arch. Gen. Psychiatry 58 6 2001 565 572 June
9. J.L. Elmslie, R.J. Porter, P.R. Joyce, P.J. Hunt, B.I. Shand, and R.S. Scott Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls Aust. NZ J. Psychiatry 43 1 2009 53 60 January
10. A. Fagiolini, E. Frank, J.A. Scott, S. Turkin, and D.J. Kupfer Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians Bipolar Disord. 7 5 2005 424 430 October
11. J.G. Fiedorowicz, N.M. Palagummi, V.L. Forman-Hoffman, D.D. Miller, and W.G. Haynes Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder Ann. Clin. Psychiatry 20 3 2008 131 137 July
12. M. Fleishman Economic grand rounds: psychopharmacosocioeconomics and the global burden of disease Psychiatr. Serv. 54 2 2003 142 144
13. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 3 2002 356 359 January 16
14. L.C. Friedman, L.J. Puryear, A. Moore, and C.E. Green Breast and colorectal cancer screening among low-income women with psychiatric disorders Psychooncology 14 9 2005 786 791 September
15. R.O. Gans The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms Med. Clin. North Am. 90 4 2006 573 591 July
16. M.P. Garcia-Portilla, P.A. Saiz, A. Benabarre, P. Sierra, J. Perez, A. Rodriguez, L. Livianos, P. Torres, and J. Bobes The prevalence of metabolic syndrome in patients with bipolar disorder J. Affect. Disord. 106 1-2 2008 197 201 February
17. B.A. Golomb, J.M. Pyne, B. Wright, B. Jaworski, J.B. Lohr, and S.A. Bozzette The role of psychiatrists in primary care of patients with severe mental illness Psychiatr. Serv. 51 6 2000 766 773 June
18. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr., and N.J. Stone Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J. Am. Coll. Cardiol. 44 3 2004 720 732 April 8
19. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, and F. Costa Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 17 2005 2735 2752 October 25 (Pubitemid 41532612)
20. J.J. Guo, P.E. Keck, H. Li, and N.C. Patel Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder Psychiatr. Serv. 58 8 2007 1073 1078
21. D.C. Henderson Managing weight gain and metabolic issues in patients treated with atypical antipsychotics J. Clin. Psychiatry 69 2 2008 e04
22. G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-Johnsen, and K. Pyorala Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Arch. Intern. Med. 164 10 2004 1066 1076 May 24
23. A.P. John, R. Koloth, M. Dragovic, and S.C. Lim Prevalence of metabolic syndrome among Australians with severe mental illness Med. J. Aust. 190 4 2009 176 179 February 16
24. Kemp D.E., Eudicone J.M., Pikalov A., Whitehead R., Chambers J.S., Baker R.A. Predictive effect of metabolic syndrome on aripiprazole treatment response. 2009. Ref Type: Unpublished Work
25. Kemp D.E., Calabrese J.R., Tran Q.V., Pikalov A., Eudicone J.M., Baker RA. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder. J Clin Psychiatry. Online ahead of print. May 4, 2010.
26. H.A. Kenna, B. Jiang, and N.L. Rasgon Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment Harv. Rev. Psychiatry 17 2 2009 138 146
27. B. Kim, S.J. Kim, J.I. Son, and Y.H. Joo Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients J. Affect. Disord. 105 1-3 2008 45 52
28. B. Kim, S. Kim, R.S. McIntyre, H.J. Park, S.Y. Kim, and Y.H. Joo Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment Psychiatry Invest. 6 2009 78 84
29. F. Levi, F. Lucchini, E. Negri, and C. La Vecchia Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world Heart 88 2 2002 119 124
30. Lourenco M.T., Woldeyohannes H.O., Law C.W., Soczynska J.K., Panjwani Z.D., Miranda A., Kennedy S.H., McIntyre R.S. Prevalence of ATP III-Defined Metabolic Syndrome in Euthymic Individuals with Bipolar I/II Disorder. 2008. Ref Type: Unpublished Work
31. J.P. McEvoy, J.M. Meyer, D.C. Goff, H.A. Nasrallah, S.M. Davis, L. Sullivan, H.Y. Meltzer, J. Hsiao, S.T. Scott, and J.A. Lieberman Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Schizophr. Res. 80 1 2005 19 32 December 1
32. R.S. McIntyre, and J.Z. Konarski Bipolar disorder: a national health concern CNS Spectr. 9 11 Suppl 12 2004 6 15 December
33. R.S. McIntyre, D.A. Mancini, S. McCann, J. Srinivasan, and S.H. Kennedy Valproate, bipolar disorder and polycystic ovarian syndrome Bipolar Disord. 5 1 2003 28 35 February
34. R.S. McIntyre, J.Z. Konarski, V.L. Misener, and S.H. Kennedy Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications Ann. Clin. Psychiatry 17 2 2005 83 93 April
35. R.S. McIntyre, J.Z. Konarski, J.K. Soczynska, K. Wilkins, G. Panjwani, B. Bouffard, A. Bottas, and S.H. Kennedy Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization Psychiatr. Serv. 57 8 2006 1140 1144 August
36. R.S. McIntyre, J.K. Soczynska, J.Z. Konarski, H.O. Woldeyohannes, C.W. Law, A. Miranda, D. Fulgosi, and S.H. Kennedy Should depressive syndromes be reclassified as "metabolic syndrome type II"? Ann. Clin. Psychiatry 19 4 2007 257 264 October
37. R.S. McIntyre, D.J. Muzina, D.E. Kemp, D. Blank, H.O. Woldeyohannes, J. Lofchy, J.K. Soczynska, S. Banik, and J.Z. Konarski Bipolar disorder and suicide: research synthesis and clinical translation Curr. Psychiatry Rep. 10 1 2008 66 72 February
38. J.M. Meyer, H.A. Nasrallah, J.P. McEvoy, D.C. Goff, S.M. Davis, M. Chakos, J.K. Patel, R.S. Keefe, T.S. Stroup, and J.A. Lieberman The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome Schizophr. Res. 80 1 2005 9 18 December 1
39. E.H. Morrato, J.W. Newcomer, R.R. Allen, and R.J. Valuck Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data J. Clin. Psychiatry 69 2 2008 316 322 February
40. H.A. Nasrallah, J.M. Meyer, D.C. Goff, J.P. McEvoy, S.M. Davis, T.S. Stroup, and J.A. Lieberman Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline Schizophr. Res. 86 1-3 2006 15 22
41. P. Nestel, R. Lyu, L.P. Low, W.H. Sheu, W. Nitiyanant, I. Saito, and C.E. Tan Metabolic syndrome: recent prevalence in East and Southeast Asian populations Asia Pac. J. Clin. Nutr. 16 2 2007 362 367
42. F. Ng, O.K. Mammen, I. Wilting, G.S. Sachs, I.N. Ferrier, F. Cassidy, S. Beaulieu, L.N. Yatham, and M. Berk The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments Bipolar Disord. 11 6 2009 559 595 September
43. U. Osby, L. Brandt, N. Correia, A. Ekbom, and P. Sparen Excess mortality in bipolar and unipolar disorder in Sweden Arch. Gen. Psychiatry 58 9 2001 844 850 September
44. P.B. Peele, Y. Xu, and D.J. Kupfer Insurance expenditures on bipolar disorder: clinical and parity implications Am. J. Psychiatry 160 7 2003 1286 1290 July
45. N.L. Rasgon, L.L. Altshuler, L. Fairbanks, S. Elman, J. Bitran, R. Labarca, M. Saad, R. Kupka, W.A. Nolen, M.A. Frye, T. Suppes, S.L. McElroy, P.E. Keck Jr., G. Leverich, H. Grunze, J. Walden, R. Post, and J. Mintz Reproductive function and risk for PCOS in women treated for bipolar disorder Bipolar Disord. 7 3 2005 246 259 June (Pubitemid 40778887)
46. N. Richter, G. Juckel, and H.J. Assion Metabolic syndrome: a follow-up study of acute depressive inpatients Eur. Arch. Psychiatry Clin. Neurosci. 260 1 2010 41 49 February
47. W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lloyd-Jones, M. McDermott, J. Meigs, C. Moy, G. Nichol, C.J. O'Donnell, V. Roger, J. Rumsfeld, P. Sorlie, J. Steinberger, T. Thom, S. Wasserthiel-Smoller, and Y. Hong Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 5 2007 e69 e171 June 2
48. V. Salvi, U. Albert, A. Chiarle, I. Soreca, F. Bogetto, and G. Maina Metabolic syndrome in Italian patients with bipolar disorder Gen. Hosp. Psychiatry 30 4 2008 318 323 July (Pubitemid 351863767)
49. M. Sarchiapone, G. Camardese, A. Roy, C.S. Della, M.A. Satta, B. Gonzalez, J. Berman, and S. De Risio Cholesterol and serotonin indices in depressed and suicidal patients J. Affect. Disord. 62 3 2001 217 219 February
50. A. Sicras, J. Rejas, R. Navarro, J. Serrat, and M. Blanca Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database Bipolar Disord. 10 5 2008 607 616 July
51. A. Sicras-Mainar, M. Blanca-Tamayo, J. Rejas-Gutierrez, and R. Navarro-Artieda Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database Eur. Psychiatry 23 2 2008 100 108 March
52. G.E. Simon, and J. Unutzer Health care utilization and costs among patients treated for bipolar disorder in an insured population Psychiatr. Serv. 50 10 1999 1303 1308
53. V. Taylor, and G. Macqueen Associations between bipolar disorder and metabolic syndrome: a review J. Clin. Psychiatry 67 7 2006 1034 1041 July
54. Teixeira P.J., Rocha F.L. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007 December;29(4):330-6
55. R. van Winkel, O.J. Van, I. Celic, E.D. Van, M. Wampers, A. Scheen, J. Peuskens, and H.M. De Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program J. Clin. Psychiatry 69 8 2008 1319 1327 August
56. R. van Winkel, A. De Hert, D. Van Eyck, L. Hanssens, M. Wampers, A. Scheen, and J. Peuskens Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder Bipolar Disorders 10 2 2008 342 348 March
57. B. Vuksan-Cusa, D. Marcinko, S. Nad, and M. Jakovljevic Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts Prog. Neuropsychopharmacol. Biol. Psychiatry 33 1 2009 109 112 February 1
58. P.W. Wilson, and S.M. Grundy The metabolic syndrome: practical guide to origins and treatment: Part I Circulation 108 12 2003 1422 1424
59. R.R. Wu, J.P. Zhao, H. Jin, P. Shao, M.S. Fang, X.F. Guo, Y.Q. He, Y.J. Liu, J.D. Chen, and L.H. Li Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial JAMA 299 2 2008 185 193
60. M. Yumru, H.A. Savas, E. Kurt, M.C. Kaya, S. Selek, E. Savas, E.T. Oral, and I. Atagun Atypical antipsychotics related metabolic syndrome in bipolar patients J. Affect. Disord. 98 3 2007 247 252 March
61. S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford, C.C. Lang, Z. Rumboldt, C.L. Onen, L. Lisheng, S. Tanomsup, P. Wangai Jr, A.M. Sharma, S.S. Anand INTERHEART Study Investigators Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study Lancet 366 9497 2005 1640 1649
62. J. Zhang, R.E. McKeown, J.R. Hussey, S.J. Thompson, J.R. Woods, and B.E. Ainsworth Low HDL cholesterol is associated with suicide attempt among young healthy women: the Third National Health and Nutrition Examination Survey J. Affect. Disord. 89 1-3 2005 25 33 December